UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 260

Sortiert nach

Chlorogenic Acid Inhibits Osteoclast Differentiation and Bone Resorption by Down-Regulation of Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor of Activated T Cells c1 Expression

Biological and Pharmaceutical Bulletin, 2013/11/01, Vol.36(11), pp.1779-1786

2013

Volltextzugriff (PDF)

Purslane Suppresses Osteoclast Differentiation and Bone Resorbing Activity via Inhibition of Akt/GSK3β-c-Fos-NFATc1 Signaling in Vitro and Prevents Lipopolysaccharide-Induced Bone Loss in Vivo

Biological and Pharmaceutical Bulletin, 2015/01/01, Vol.38(1), pp.66-74

2015

Volltextzugriff (PDF)

Genipin Inhibits RANKL-Induced Osteoclast Differentiation Through Proteasome-Mediated Degradation of c-Fos Protein and Suppression of NF-κB Activation

Journal of Pharmacological Sciences, 2014/03/20, Vol.124(3), pp.344-353

2014

Volltextzugriff (PDF)

(2S)-2′-Methoxykurarinone Inhibits Osteoclastogenesis and Bone Resorption through Down-Regulation of RANKL Signaling

Biological and Pharmaceutical Bulletin, 2014/02/01, Vol.37(2), pp.255-261

2014

Volltextzugriff (PDF)

Protocatechuic Acid Attenuates Osteoclastogenesis by Downregulating JNK/c-Fos/NFATc1 Signaling and Prevents Inflammatory Bone Loss in Mice

Phytotherapy research, 2016-04, Vol.30 (4), p.604-612

2016

Volltextzugriff (PDF)

Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression

Bone (New York, N.Y.), 2010-03, Vol.46 (3), p.724-731

2010

Volltextzugriff (PDF)

Dendrobium moniliforme Exerts Inhibitory Effects on Both Receptor Activator of Nuclear Factor Kappa-B Ligand-Mediated Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Bone Erosion in Vivo

Molecules (Basel, Switzerland), 2016-03, Vol.21 (3), p.295-295

2016

Volltextzugriff (PDF)

Niclosamide suppresses RANKL-induced osteoclastogenesis and prevents LPS-induced bone loss

Biochemical and biophysical research communications, 2016-02, Vol.470 (2), p.343-349

2016

Volltextzugriff (PDF)

Anti-osteoclastogenic activity of praeruptorin A via inhibition of p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca2+ oscillation

PloS one, 2014-02, Vol.9 (2), p.e88974-e88974

2014

Volltextzugriff (PDF)

Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo

Molecules (Basel, Switzerland), 2014-11, Vol.19 (11), p.18465-18478

2014

Volltextzugriff (PDF)

Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone loss in mice

Molecules (Basel, Switzerland), 2014-08, Vol.19 (8), p.11628-11644

2014

Volltextzugriff (PDF)

Synthesis of laboratory Ultrasound Contrast Agents

Molecules (Basel, Switzerland), 2013-10, Vol.18 (10), p.13078-13095

2013

Volltextzugriff (PDF)

Inhibitory regulation of osteoclast differentiation by interleukin-3 via regulation of c-Fos and Id protein expression

Journal of cellular physiology, 2012-05, Vol.227 (5), p.1851-1860

2012

Volltextzugriff (PDF)

Massive elimination of multinucleated osteoclasts by eupatilin is due to dual inhibition of transcription and cytoskeletal rearrangement

Bone Reports, 2015-12, Vol.3 (C), p.83-94

2015

Volltextzugriff (PDF)

Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2–Ca2+-NFATc1 signaling, and suppresses bone loss in mice

Bone (New York, N.Y.), 2014-03, Vol.60, p.104-111

2014

Volltextzugriff (PDF)

Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells

International journal of molecular medicine, 2015-12, Vol.36 (6), p.1664-1670

2015

Volltextzugriff (PDF)

Risedronate Directly Inhibits Osteoclast Differentiation and Inflammatory Bone Loss

Biological and Pharmaceutical Bulletin, 2009/07/01, Vol.32(7), pp.1193-1198

2009

Volltextzugriff (PDF)

Effect of interferon-γ on the fusion of mononuclear osteoclasts into bone-resorbing osteoclasts

BMB Reports, 2012, 45(5), , pp.281-286

2012

Volltextzugriff (PDF)

Pyridone 6, A Pan-Janus-Activated Kinase Inhibitor, Suppresses Osteoclast Formation and Bone Resorption through Down-Regulation of Receptor Activator of Nuclear Factor-κB (NF-κB) Ligand (RANKL)-Induced c-Fos and Nuclear Factor of Activated T Cells (NFAT) c1 Expression

Biological and Pharmaceutical Bulletin, 2009/01/01, Vol.32(1), pp.45-50

2009

Volltextzugriff (PDF)

Proteasome inhibitors induce osteoclast survival by activating the Akt pathway

Biochemical and biophysical research communications, 2008-12, Vol.377 (1), p.1-6

2008

Volltextzugriff (PDF)

Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway

BMB Reports, 2012, 45(3), , pp.171-176

2012

Volltextzugriff (PDF)

Emodin Regulates Bone Remodeling by Inhibiting Osteoclastogenesis and Stimulating Osteoblast Formation

Journal of bone and mineral research, 2014-07, Vol.29 (7), p.1541-1553

2014

Volltextzugriff (PDF)

GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway

The Journal of immunology (1950), 2009-09, Vol.183 (5), p.3390-3399

2009

Volltextzugriff (PDF)

Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLC gamma 2-Ca2+-NFATc1 signaling, and suppresses bone loss in mice

Bone (New York, N.Y.), 2014-03, Vol.60, p.104-111

2014

Volltextzugriff (PDF)

CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo

Bone (New York, N.Y.), 2015-10, Vol.79, p.242-251

2015

Volltextzugriff (PDF)

1 – 25 von 260

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(241)

Publikationsform

Sprache

Englisch
(236)
Japanisch
(22)
Koreanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(98)
Male
(56)
Animals
(54)
Humans
(54)
Technology
(47)
Mice
(36)
Female
(33)
Physical Sciences
(31)
Atrial Fibrillation
(29)
Cell Differentiation - Drug Effects
(28)
Science & Technology - Other Topics
(27)
Mice, Inbred Icr
(26)
Middle Aged
(26)
Osteoclasts - Drug Effects
(26)
Osteoclast
(25)
Osteoclasts - Cytology
(24)
Osteoporosis
(24)
Cardiovascular System & Cardiology
(21)
Chemistry
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Chlorogenic Acid Inhibits Osteoclast Differentiation and Bone Resorption by Down-Regulation of Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor of Activated T Cells c1 Expression

Purslane Suppresses Osteoclast Differentiation and Bone Resorbing Activity via Inhibition of Akt/GSK3β-c-Fos-NFATc1 Signaling in Vitro and Prevents Lipopolysaccharide-Induced Bone Loss in Vivo

Genipin Inhibits RANKL-Induced Osteoclast Differentiation Through Proteasome-Mediated Degradation of c-Fos Protein and Suppression of NF-κB Activation

(2S)-2′-Methoxykurarinone Inhibits Osteoclastogenesis and Bone Resorption through Down-Regulation of RANKL Signaling

Protocatechuic Acid Attenuates Osteoclastogenesis by Downregulating JNK/c-Fos/NFATc1 Signaling and Prevents Inflammatory Bone Loss in Mice

Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression

Dendrobium moniliforme Exerts Inhibitory Effects on Both Receptor Activator of Nuclear Factor Kappa-B Ligand-Mediated Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Bone Erosion in Vivo

Niclosamide suppresses RANKL-induced osteoclastogenesis and prevents LPS-induced bone loss

Anti-osteoclastogenic activity of praeruptorin A via inhibition of p38/Akt-c-Fos-NFATc1 signaling and PLCγ-independent Ca2+ oscillation

Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo

Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone loss in mice

Synthesis of laboratory Ultrasound Contrast Agents

Inhibitory regulation of osteoclast differentiation by interleukin-3 via regulation of c-Fos and Id protein expression

Massive elimination of multinucleated osteoclasts by eupatilin is due to dual inhibition of transcription and cytoskeletal rearrangement

Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2–Ca2+-NFATc1 signaling, and suppresses bone loss in mice

Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells

Risedronate Directly Inhibits Osteoclast Differentiation and Inflammatory Bone Loss

Effect of interferon-γ on the fusion of mononuclear osteoclasts into bone-resorbing osteoclasts

Pyridone 6, A Pan-Janus-Activated Kinase Inhibitor, Suppresses Osteoclast Formation and Bone Resorption through Down-Regulation of Receptor Activator of Nuclear Factor-κB (NF-κB) Ligand (RANKL)-Induced c-Fos and Nuclear Factor of Activated T Cells (NFAT) c1 Expression

Proteasome inhibitors induce osteoclast survival by activating the Akt pathway

Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway

Emodin Regulates Bone Remodeling by Inhibiting Osteoclastogenesis and Stimulating Osteoblast Formation

GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway

Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLC gamma 2-Ca2+-NFATc1 signaling, and suppresses bone loss in mice

CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo

Suchergebnisse filtern